Analytical Data
-
基因名
MYNN
- Application
-
别名
MYNN; MYNN_HUMAN; Myoneurin; OSZF; SBBIZ1; ZBTB31; Zinc finger and BTB domain containing protein 31 ; Zinc finger and BTB domain-containing protein 31; Zinc finger protein with BTB/POZ domain; ZNF902
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9NPC7
-
表达区间
1-610 aa
-
氨基酸序列
MQYSHHCEHL LERLNKQREA GFLCDCTIVI GEFQFKAHRN VLASFSEYFG AIYRSTSENN VFLDQSQVKA DGFQKLLEFI YTGTLNLDSW NVKEIHQAAD YLKVEEVVTK CKIKMEDFAF IANPSSTEIS SITGNIELNQ QTCLLTLRDY NNREKSEVST DLIQANPKQG ALAKKSSQTK KKKKAFNSPK TGQNKTVQYP SDILENASVE LFLDANKLPT PVVEQVAQIN DNSELELTSV VENTFPAQDI VHTVTVKRKR GKSQPNCALK EHSMSNIASV KSPYEAENSG EELDQRYSKA KPMCNTCGKV FSEASSLRRH MRIHKGVKPY VCHLCGKAFT QCNQLKTHVR THTGEKPYKC ELCDKGFAQK CQLVFHSRMH HGEEKPYKCD VCNLQFATSS NLKIHARKHS GEKPYVCDRC GQRFAQASTL TYHVRRHTGE KPYVCDTCGK AFAVSSSLIT HSRKHTGEKP YICGICGKSF ISSGELNKHF RSHTGERPFI CELCGNSYTD IKNLKKHKTK VHSGADKTLD SSAEDHTLSE QDSIQKSPLS ETMDVKPSDM TLPLALPLGT EDHHMLLPVT DTQSPTSDTL LRSTVNGYSE PQLIFLQQLY
-
分子量
68.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
MYNN is a relatively novel protein that has garnered interest in the field of molecular biology due to its potential roles in various cellular processes, including cell signaling, proliferation, and differentiation. Research on MYNN has intensified in recent years as it has been implicated in several diseases, including cancer and neurological disorders. Studies suggest that MYNN may function as a modulator of key signaling pathways, contributing to tumorigenesis and the progression of certain brain diseases. Understanding its structure and function is crucial for deciphering its biological significance and therapeutic potential. Advanced techniques, such as recombinant protein expression and purification, are being employed to produce MYNN for further investigation. By elucidating the mechanisms through which MYNN influences cellular behavior, researchers aim to identify novel biomarkers or therapeutic targets that could lead to innovative treatment strategies for diseases where MYNN plays a critical role. The ongoing research on MYNN not only enhances our understanding of its fundamental biological roles but also paves the way for potential clinical applications that could improve patient outcomes in conditions associated with altered MYNN activity.
